Sarah Jessica Parker Ends Mylan Partnership Over EpiPen Price Hike

Sarah Jessica Parker has ended her relationship with the controversial pharmaceutical company Mylan.  In May, the actress joined forces with the makers of the EpiPen through a campaign called Anaphylaxis for Reel. At the time, Parker urged awareness for life-threatening allergies and revealed that the issue is personal for her because her 13-year-old son, James Wilke Broderick has a severe peanut and hazelnut allergy.  But following reports that the company raised the price of their standard two-pack of EpiPens from $100 in 2009 to $600 in 2016, Parker publicly cut ties and condemned the price hike. “I’m left disappointed, saddened and deeply concerned by Mylan’s actions,” she said in her statement on Instagram. Her original ad from May:  It’s been an honor working with the #AnaphylaxisForReel initiative as a #spokesperson for Mylan this past month and encouraging people to share their stories about managing potentially life-threatening (severe) allergies. As the mother of a child with severe allergies, raising awareness and starting a discussion about the risks of anaphylaxis is so important to me. Join the cause by sharing your experiences at Anaphylaxis101.com. X, Sj A photo posted by SJP (@sarahjessicaparker) on Jun 14, 2016 at 6:32am PDT Parker and her son, James Wilke: Parker issued a statement on her Instagram account denouncing her relationship with Mylan, expressing her disappointment in the company’s ...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news